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In this issue of the Journal, Kosek and colleagues 
report the results of an exercise conducted by lead-
ing experts in diarrhoea, ranking different topics in 
diarrhoea research according to their potential to 
contribute to a substantial reduction in diarrhoeal 
disease by 2015 in accordance with the Millennium 
Development Goals (MDGs) (1). It is always easy to 
criticize the outcome of such expert panels. Inevi-
tably, some researchers may feel that the merits of 
their particular research field were not sufficiently 
appreciated. It can be argued, however, that such 
exercises are useful if the results are interpreted ap-
propriately. 
In summing up the scores allocated to different 
research options, the authors found that priority 
was given predominantly to medical interventions 
and to health services research aiming at scaling 
up their delivery. Efficacy trials and health services 
research relating to rotavirus vaccination, zinc sup-
plementation, and low-osmolarity oral rehydration 
solutions consistently achieved the highest scores. 
As the authors noted, it came a bit as a surprise that 
research on nutrition (other than micronutrients) 
and on water, sanitation, and hygiene received 
much more modest scores. However, there is some 
logic behind this assessment, given that the experts 
were constrained to judging the merit of a particular 
research topic with regard to its potential to make a 
measurable contribution to reducing the burden of 
diarrhoea, in particular mortality, by 2015 (the dead-
line for the MDGs). Nutrition, water, sanitation, 
and hygiene are all rather complex research fields 
comprising numerous behavioural, political and 
economic aspects, which make them unlikely can-
didates for contributing substantially to reduction in 
diarrhoea by 2015. Instead, the experts recommend 
prioritizing clinical solutions, with the potential for 
a quick impact, especially on case-fatality. The ques-
tion, therefore, arises whether it was legitimate in 
the first place to assess the different research options 
based on their potential to make an impact by 2015. 
This deadline must have made it difficult for the as-
sessors to attribute any merit to complex interven-
tions, for which scaling up has been found an ongo-
ing challenge. Because some interventions require 
more time to develop than others, or by their nature 
cannot be tested in a double-blind randomized trial, 
it does not mean that these are less important in the 
longer term, nor necessarily that we can afford de-
laying further research at this stage.
Food, water, and sanitation are perhaps the three 
most important determinants of future human 
welfare. They are deeply affected by some of our 
greatest global challenges, such as the over-exploi-
tation of land and resources, population growth, 
and climate change. It seems difficult to deny the 
merit of allocating more research efforts on how to 
bring these essential components of health and sus-
tainable development to those with limited access 
to them. On these grounds, it can be argued that 
any deadline set by the international community 
to reach a certain development goal should only in-
fluence the speed at which interventions recognized 
as essential are implemented. The choice between 
different interventions may be better based on a 
longer-term potential, since the world (hopefully) 
will not come to a sudden end in 2015. Further, it 
is possible that, for example, research on rotavirus 
vaccines 10 years ago would not have been given 
top priority if a similar exercise for an equally short 
timeframe had been conducted. Today, however, 
rotavirus vaccines are regarded as one of the most 
promising tools in diarrhoea control (although 
their effect on all-cause mortality in low-income 
settings has not yet been demonstrated). Thus, the 
2015 deadline might not only discourage the priori- 
tizing of complex interventions but may discour-
age innovation altogether. 
Kosek and colleagues suggest that the 2015 dead-
line may have particularly favoured health services 
research options, especially those on scaling up mi-
cronutrient supplementation and oral rehydration 
solutions. One may wonder at this point why so 
many health services research options were includ-Schmidt WP Merits and pitfalls of expert opinion
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ed in the exercise in the first place. As important 
as health services research on individual interven-
tions is, it could be balanced with research on how 
to strengthen health services for diarrhoea control 
in more general terms, independent of a particular 
type of intervention that may fall out of fashion a 
few years down the line. A cynic might suggest that 
the sheer number of individual health services re-
search topics included may have increased the like-
lihood of finding some of them in the top ranks. 
Another factor that may have favoured clinical 
research options is the choice of the five criteria 
according to which the different research options 
were assessed: (a) The likelihood that the research 
option can yield new knowledge; (b) The likelihood 
that the research findings will lead to effective in-
terventions; (c) The likelihood that the interven-
tion derived from the research would be affordable 
and deliverable; (d) The most likely maximum bur-
den of disease reduction; and (e) Impact on equity. 
It might have been worthwhile to include the fol-
lowing two further criteria, due to their importance 
when it comes to making policy decisions (2): (a) 
The likelihood that an intervention causes adverse 
effects and (b) The potential for an intervention 
to deliver non-health or indirect health benefits. 
Clinical approaches to diarrhoea control do not 
look very good in this regard. Although the risks 
of adverse effects may not be very large, there is al-
ways the risk that, for example, supplementation of 
micronutrients is only beneficial to certain popula-
tions and detrimental to others, for example, when 
given as a prophylaxis (3). Further, clinical solu-
tions are rarely associated with benefits other than 
treating or preventing diarrhoea. This contrasts, for 
example, with research on scaling up school sani-
tation in low-income settings. School sanitation is 
not expected to be associated with any adverse ef-
fects but, in addition to contributing to the control 
of diarrhoea, helminths, and trachoma, it encour-
ages school attendance, especially of girls, and may 
in the longer term increase demand for sanitation 
in the community as a whole (4). Should these as-
pects not be taken into consideration in the process 
of allocating research priorities?  
The experts chosen for this exercise were individuals 
with impressive track records of research on many 
different public-health and clinical aspects of diar-
rhoea. Most of them may be regarded as generalists 
well-placed to judge on the wide range of differ-
ent research options. However, one may question 
whether it was necessary to include almost exclu-
sively medical doctors in the expert panel, leaving 
out professions, such as nutritional science, engi-
neering, health policy, or environmental health. As 
a consequence of its composition, the panel may 
have been over-optimistic in judging the likeli-
hood of scaling up medical interventions by 2015 
through enhanced health services research. Many 
medical interventions have been around for decades 
and still do not reach those who need them most 
(5). Improving health services may be as complex as 
scaling up sanitation or nutrition interventions. 
It could be argued that only doctors are informed 
enough to judge the merit of different clinical inter-
ventions and, at the same time, provide expertise in 
nutrition and environmental health. However, en-
vironmental health engineers or nutritionists may 
be as able to assume some ‘collateral expertise’, as 
one might call it, in the medical domain as medi-
cal doctors assume in the field of environmental 
health and nutrition. It may even be much easier 
to interpret the findings of a double-blind random-
ized trial of a medical intervention than research 
studies on complex environmental or nutritional 
interventions.
Would the exercise have benefited from first estab-
lishing a multidisciplinary expert panel to come up 
with the most useful question (which may have 
excluded the 2015 deadline), then using an expert 
panel to come up with a balanced list of research 
options; further, an expert panel to decide on the 
most suitable criteria according to which these 
research options are assessed; and finally, an ex-
pert panel to discuss what kind of experts should 
be involved in the actual exercise? It sounds a bit 
technocratic, and we cannot be certain that simply 
increasing the total number of expert panels would 
have strengthened the validity of the outcome. 
However, inclusion of a wider range of professions 
from the beginning may have helped avoid bias. 
The authors aimed at providing “a quantitative 
measure of the collective optimism that research 
in that area can have substantial impact prior to 
the year 2015.” It is easy to criticize such a claim 
but does this mean the outcome of the exercise has 
little validity, or does not provide any insights that 
common sense would not have dictated anyway? 
For all their faults, expert panels as described here 
can be useful or even indispensable, simply because 
common sense does not always prevail in allocat-
ing research funds. Ideological, political and com-
mercial considerations, at times, seem much more 
appealing to decision-makers than common sense. 
For example, it is hard to imagine what could be 
achieved if the research efforts invested by the Schmidt WP Merits and pitfalls of expert opinion
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pharmaceutical industry (largely funded by public-
health insurance) into the development of ‘me-too’ 
drugs without additional health benefit compared 
to the original formulation could be channelled to-
wards something more widely useful. 
On the whole, despite the caveats outlined above, 
the article by Kosek and colleagues provides several 
important insights: First, there is little doubt that 
health services research into scaling up proven in-
terventions should have a prominent role in short- 
or long-term research funding strategies. Second, as 
the authors point out, inferior scores for a particular 
public-health intervention may even indicate that 
more research needs to be done to strengthen the 
case for the intervention. The research topics with 
the highest scores may, in fact, represent those that 
already attracted considerable research efforts and 
funding in the past. At the risk of over-simplifying 
matters, it may be worthwhile to turn the ranking 
list upside down in the search for neglected fields 
requiring more attention. 
Third, the result of the exercise may encourage 
researchers in such neglected fields to ask why it 
is that their field has attracted less research fund-
ing than hoped for. Possibly, the medical field has 
been better at conducting high-quality trials than 
nutritionists or water and sanitation researchers. 
In these fields, far-reaching policy decisions are at 
times based on a largely-unacceptable evidence 
base, as exemplified by the widespread promotion 
of growth monitoring (6). There are many other 
reasons why medical interventions regularly attract 
more funding, for example, due to commercial in-
terests, professional lobbying, a favourable public 
relations environment, or simply the option to 
double-blind interventions. However, insufficient 
emphasis on methodological rigour in nutrition 
and environmental health studies may also have 
contributed to this situation. 
Thus, the results of this exercise offer a multitude of 
interpretations to inform research funders. As the 
authors point out, the results do not prevent others 
from conducting a similar exercise on diarrhoeal 
disease research priorities, this time accounting for 
long-term issues, including global resources, cli-
matic and demographic trends. Taking a long-term 
perspective on diarrhoea control may even dimin-
ish the need for clinical solutions. 
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